Aktive Positionen von Michael R. Simon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Secretory IgA, Inc.
 Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Gründer | 20.09.2011 | - |
| Präsident | 20.09.2011 | - | |
| Wayne State University (Michigan) | Corporate Officer/Principal | 20.09.2011 | - |
Karriereverlauf von Michael R. Simon
Ausbildung von Michael R. Simon
| New York University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Founder | 1 |
| President | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Secretory IgA, Inc.
Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Health Technology |
- Börse
- Insiders
- Michael R. Simon
- Erfahrung
